{"id":"W4409255937","doi":"10.1016/bs.ircmb.2025.03.002","title":"Interleukin-33: A new frontier in cancer immunotherapy","year":2025,"lang":"en","type":"book-chapter","venue":"International review of cell and molecular biology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Institute for Cancer Research, Keimyung University; Fraser Institute; Canadian Institutes of Health Research; University of Queensland; Canadian Cancer Society; Cumming School of Medicine, University of Calgary; University of Calgary; Australian Government; Alberta Cancer Foundation; Cancer Research Society; Cancer Council NSW; National Health and Medical Research Council; Arnie Charbonneau Cancer Institute, University of Calgary","keywords":"Biology; Immunotherapy; Cancer immunotherapy; Frontier; Cancer; Immunology; Interleukin 15; Cancer research; Interleukin; Cytokine; Immune system; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002477759,0.0005216833,0.0004723798,0.0005822551,0.000227892,0.001001682,0.0003839501,0.0007156593,0.007749983],"category_scores_gemma":[0.0001873708,0.0001644261,0.0002022391,0.0007258533,0.0003714804,0.001306471,0.0006003741,0.002150754,0.002981865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003674461,"about_ca_system_score_gemma":0.0006263297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003486249,"about_ca_topic_score_gemma":0.001151445,"domain_scores_codex":[0.9999368,0.00001108521,0.000002415962,0.000009210174,0.00002889909,0.00001163549],"domain_scores_gemma":[0.9999381,0.00003221533,0.0000044116,0.000002587544,0.00001036393,0.0000122737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001423629,0.00008865306,0.0001188386,0.001316756,0.00001300825,0.0002530141,0.00009432444,0.000445435,0.01959965,0.060303,0.2212758,0.6963493],"study_design_scores_gemma":[0.00001039726,0.00004116155,0.0001457889,0.0002301039,0.000006002684,0.0003900084,0.00003209014,0.0001181437,0.001027407,0.009710986,0.988282,0.000005956289],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001311556,0.9565243,0.004590228,0.006518046,0.004124016,0.00002520349,0.0001066502,0.00009457599,0.02670548],"genre_scores_gemma":[0.01249551,0.8984656,0.006309499,0.003901701,0.003759475,0.00006797157,0.0001684273,0.00004328784,0.07478838],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007749983,"threshold_uncertainty_score":0.02592623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008715281310847306,"score_gpt":0.2748627150565083,"score_spread":0.266147433745661,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}